Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,255 | 704 | 90.9% |
| Education | $1,122 | 16 | 9.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,223 | 183 | $0 (2024) |
| Janssen Biotech, Inc. | $2,146 | 136 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,302 | 94 | $0 (2024) |
| UCB, Inc. | $877.65 | 74 | $0 (2024) |
| Lilly USA, LLC | $767.75 | 43 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $671.28 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $464.15 | 15 | $0 (2024) |
| GENZYME CORPORATION | $395.70 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $394.09 | 18 | $0 (2024) |
| LEO Pharma Inc. | $375.29 | 36 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,134 | 158 | ABBVIE INC. ($778.61) |
| 2023 | $3,607 | 199 | ABBVIE INC. ($835.39) |
| 2022 | $2,830 | 176 | ABBVIE INC. ($851.32) |
| 2021 | $2,806 | 187 | AbbVie Inc. ($757.74) |
All Payment Transactions
720 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.12 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $37.71 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Immunology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,019 | 1,827 | $284,124 | $63,470 |
| 2022 | 10 | 952 | 1,756 | $250,100 | $55,572 |
| 2021 | 10 | 807 | 1,525 | $221,884 | $53,195 |
| 2020 | 12 | 771 | 1,358 | $193,765 | $42,854 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 253 | 391 | $89,930 | $19,817 | 22.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 109 | 129 | $37,473 | $8,916 | 23.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 181 | 246 | $41,417 | $7,895 | 19.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 105 | 115 | $30,597 | $7,102 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 112 | 112 | $31,920 | $7,078 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 65 | $21,450 | $4,612 | 21.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 125 | 685 | $11,350 | $3,032 | 26.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 15 | $4,998 | $1,292 | 25.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 13 | $5,500 | $1,288 | 23.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 27 | $3,651 | $993.33 | 27.2% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 15 | $3,808 | $879.51 | 23.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $2,030 | $564.90 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 221 | 289 | $66,470 | $14,618 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 110 | $36,300 | $8,111 | 22.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 195 | 243 | $40,911 | $7,793 | 19.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 89 | 98 | $26,074 | $6,055 | 23.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 78 | 88 | $25,563 | $5,857 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $25,365 | $5,616 | 22.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 145 | 782 | $12,958 | $3,378 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $9,350 | $2,224 | 23.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 12 | 12 | $3,999 | $1,108 | 27.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 15 | 23 | $3,110 | $810.94 | 26.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 315 | $70,930 | $17,620 | 24.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 76 | 90 | $26,081 | $6,821 | 26.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 147 | 190 | $32,303 | $6,377 | 19.7% |
About Kelli Farm, NP
Kelli Farm, NP is a Family healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1639568496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelli Farm, NP has received a total of $12,377 in payments from pharmaceutical and medical device companies, with $3,134 received in 2024. These payments were reported across 720 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($11,255).
As a Medicare-enrolled provider, Farm has provided services to 3,549 Medicare beneficiaries, totaling 6,466 services with total Medicare billing of $215,092. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Salem, OR
- Active Since 01/16/2015
- Last Updated 07/17/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639568496
Products in Payments
- SKYRIZI (Biological) $2,422
- TREMFYA (Drug) $1,757
- DUPIXENT (Biological) $1,350
- TALTZ (Drug) $719.45
- RINVOQ (Biological) $688.56
- COSENTYX (Drug) $678.46
- Cimzia (Drug) $661.13
- COSENTYX (Biological) $583.31
- Sotyktu (Drug) $394.09
- REMICADE (Biological) $389.49
- OPZELURA (Drug) $352.56
- Otezla (Drug) $305.27
- ILUMYA (Biological) $248.02
- ADBRY (Biological) $239.02
- Bimzelx (Biological) $216.52
- AMELUZ (Drug) $146.27
- EUCRISA (Drug) $144.68
- ENSTILAR (Drug) $111.27
- VTAMA (Drug) $99.60
- IDACIO (Biological) $81.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Salem
Dr. Christopher Gessel, Np, NP
Family — Payments: $19,312
Pamela Price, Np, NP
Family — Payments: $15,044
Neeta Vorst, Fnp, FNP
Family — Payments: $14,287
Mrs. Kelly Link, Np-C, NP-C
Family — Payments: $8,038
Mrs. Beth Hite, Np-C, NP-C
Family — Payments: $6,450
Sarah Markwood, Fnp, FNP
Family — Payments: $4,890